Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3528247010 | Interleukin 5 receptor antagonist | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3528248017 | Interleukin 5 receptor antagonist (disposition) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 7506751000172114 | interleukine-5-receptorantagonist | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 7506761000172111 | IL-5-receptorantagonist | nl | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Interleukin 5 receptor antagonist | Is a | Interleukin receptor antagonist (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Substance with interleukin 5 receptor antagonist mechanism of action (substance) | Has disposition (attribute) | True | Interleukin 5 receptor antagonist | Inferred relationship | Some | |
| Mepolizumab (substance) | Has disposition (attribute) | True | Interleukin 5 receptor antagonist | Inferred relationship | Some | |
| Reslizumab (substance) | Has disposition (attribute) | True | Interleukin 5 receptor antagonist | Inferred relationship | Some |
This concept is not in any reference sets
FHIR